NDC 57894-501

Rybrevant

Amivantamab

Rybrevant is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Janssen Biotech, Inc.. The primary component is Amivantamab.

• Product ID: 57894-501_1bbf01c9-c1de-48b8-bf7c-4c56a40d70ff
• NDC: 57894-501
• Product Type: Human Prescription Drug
• Proprietary Name: Rybrevant
• Generic Name: Amivantamab
• Dosage Form: Injection
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2021-05-21
• Marketing Category: BLA /
• Application Number: BLA761210
• Labeler Name: Janssen Biotech, Inc.
• Substance Name: AMIVANTAMAB
• Active Ingredient Strength: 350 mg/1
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 57894-501-01

1 VIAL, SINGLE-USE in 1 CARTON (57894-501-01) > 1 INJECTION in 1 VIAL, SINGLE-USE (57894-501-00)

• Marketing Start Date: 2021-05-21
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details